Brazil's decision came after Bharat Biotech terminated its pact with the country after its deal to supply 20 million Covaxin doses attracted investigation by Brazilian authorities.
The Jair Bolsonaro-led Brazil government cancelled Indian drugmaker Bharat Biotech’s emergency use authorisation request for its Covaxin vaccine on 24 July.
The termination came after the deal with the Brazilian Government for the supply of 20 million doses of the Covaxin landed in controversy and attracted investigation by authorities.
Bharat Biotech Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its vaccine for the Brazilian market.
Brazil Tuesday suspended its deal with Bharat Biotech for 20 million Covaxin doses amid an ongoing investigation into alleged irregularities & corruption. ThePrint gives you the details.
Bharat Biotech's Covaxin contract to Brazil landed in controversy after the South American Attorney General reportedly launched a probe into the deal to purchase 20 million doses.
P.2 or B.1.1.28.2 variant of SARS-CoV-2, however, has so far had very less prevalence, with less than 0.5% of the viral samples detected worldwide showing this strain.
The no-fuss change of government in Bihar, without horse-trading or MLAs in resorts, has prompted a coalition partner to request the CM to make arrangements for a trip to a hill station.
Frank Kendall, Secretary of the US Air Force, says the unescorted access to Pentagon for Indian defence attaché 'is aligned with the trust and cooperation we share'.